Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 22, 2020
High lifetime, but low current, prevalence of new psychotropic substances (NPS) use in German drug detoxification treatment young inpatientsNorbert Scherbaum, Friedrich Seiffert, Fabrizio Schifano, et al.
Pharmacopsychiatry|October 30, 2024
Evaluation of E-Cigarette Use in Opioid-Dependent Patients in Maintenance TreatmentJosef Rabl, Michael Specka, Udo Bonnet, et al.
Frontiers in Psychiatry|October 2, 2023
Opiate maintenance patients' attitudes and self-reported adherence to protective measures against SARS-CoV-2 infectionsMichael Specka, Tobias Kröckert, Mirko Trilling, et al.
British Journal of Pharmacology|July 14, 2004
Levetiracetam inhibits Na+-dependent Cl-/HCO3- exchange of adult hippocampal CA3 neurons from guinea-pigsTobias Leniger, Jan Thöne, Udo Bonnet, et al.
Epilepsia|May 25, 2002
Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neuronsTobias Leniger, Martin Wiemann, Dieter Bingmann, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|February 17, 2021
Opioid painkiller dependence in a sample of elderly medical inpatientsStefania Chiappini, Fabrizio Schifano, Giovanni Martinotti, et al.
Frontiers in Psychiatry|December 21, 2020
Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?Benedikt Bernd Claus, Michael Specka, Heath McAnally, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|December 19, 2009
An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocolUdo Bonnet, Reza Hamzavi-Abedi, Michael Specka, et al.
Deutsches Arzteblatt International|May 6, 2015
Risks associated with the non-medicinal use of cannabisEva Hoch, Udo Bonnet, Rainer Thomasius, et al.
International Journal of Environmental Research and Public Health|December 24, 2021
New Access Routes to Undertreated Populations; How Do Problem Substance Users Recruited from an Unemployment Office Differ from Detoxification Treatment Inpatients?Norbert Scherbaum, Thomas Mikoteit, Lilia Witkowski, et al.
Pageof 9